Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phthisis Diagnostics Announces Second Round of Funding

Published: Thursday, July 12, 2012
Last Updated: Thursday, July 12, 2012
Bookmark and Share
With their first product already in the international marketplace and a second just launched, Phthisis Diagnostics has announced a successful second round of angel funding.

The original investors, Piedmont Angel Network and New Dominion Angels, have contributed $147,500 to this round and seven more investors have committed an additional $262,500 for a total of $410,000 in fresh funding.  New investors in Phthisis Diagnostics include Piedmont Investment Advisors LLC (through its affiliate Militello Capital), MooDoos Limited Partnership, Ronald Harris, Virga Ventures LLC, Daniel Brody, and Afton Scientific NA LLC.

“We are delighted to have this additional investor support.  This will enable us to continue marketing our existing products and to continue expansion of our product lines,” observed Crystal Icenhour, PhD, President and Chief Science Officer for Phthisis.  “The funding will be used to complete development and clinical trials for our first diagnostic for parasites.  We expect to release this molecular diagnostic product within the next 18 months.  Additional diagnostics for fungi and mycobacterium, as well as molecular standards for improved laboratory quality control, are also in development.”

“We are excited about the rapid progress the Phthisis team has made and their clear path to success,” said Bill Militello, Managing Principal at Piedmont Investment Advisors, a Leesburg, VA-based investment firm (www.piedmontRIA.com). The enthusiasm is shared by Andy Dreyfuss, Fund Executive for the Piedmont Angel Network, who noted “The Piedmont Angel Network has been pleased with the progress made by Phthisis Diagnostics since the spring of 2011 and continues to be excited about the release of the company’s first molecular diagnostic test for parasites scheduled for early 2013.” The firm is headquartered in Winston-Salem, NC.

Recently, Dr. Icenhour was featured as one of “40 Medtech Innovators Under 40” by industry publication MD+DI Medical Device and Diagnostic Industry News Products and Suppliers.  Earlier this spring she was recognized with a prestigious national award for her success as an entrepreneur, combining science and business, when she was named the 2012 Ewing Marion Kauffman Foundation Outstanding Postdoctoral Entrepreneur by the Foundation and the National Postdoctoral Association (NPA).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phthisis Diagnostics Announces First International Distribution Agreement
Simple and cost-efficient molecular products make their way into Latin America.
Friday, May 25, 2012
Phthisis Diagnostics Welcomes New Sales Director and Controller
Appointment of Betty Polk and Robert Owen to Company’s management team.
Monday, May 14, 2012
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
NIH Sequences Genome of a Fungus
Researchers at the Institute have sequenced genome of human, mouse and rat Pneumocystis that cause life-threatening Pneumonia in immunosuppressed hosts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!